News

The Warren Center for Neuroscience Drug Discovery at Vanderbilt University consists of a remarkable community dedicated to advancing the translation of basic science to novel therapeutics to treat serious brain disorders. In addition to our outstanding faculty, postdocs, and trainees who are at the forefront of our cutting-edge research, a… Read More

The Warren Center for Neuroscience Drug Discovery at Vanderbilt University consists of a remarkable community dedicated to advancing the translation of basic science to novel therapeutics to treat serious brain disorders. In addition to our outstanding faculty, postdocs, and trainees who are at the forefront of our cutting-edge research, a… Read More

𝐍𝐌𝐑𝐀-𝟖𝟔𝟏, a novel muscarinic M4 positive allosteric modulator (PAM) discovered at the Warren Center for Neuroscience Drug Discovery (WCNDD), has entered Phase 1 clinical trials in collaboration with Neumora Therapeutics. Read the Press release here →… Read More

The Warren Center for Neuroscience Drug Discovery at Vanderbilt University consists of a remarkable community dedicated to advancing the translation of basic science to novel therapeutics to treat serious brain disorders. In addition to our outstanding faculty, postdocs, and trainees who are at the forefront of our cutting-edge research, a… Read More

The Warren Center for Neuroscience Drug Discovery (WCNDD) has partnered with Ono Pharmaceutical Co., Ltd. to develop novel compounds targeting TREK channels—key regulators of neuronal excitability and pain signaling. This collaboration exemplifies the power of academic-industry partnerships in accelerating neuroscience innovation and advancing new therapeutic strategies for neurological… Read More

Craig Lindsley was featured on the Vanderbilt University’s Quantum Potential podcast, Dr. Craig Lindsley— Executive Director of the Warren Center for Neuroscience Drug Discovery—joins Provost C. Cybele Raver to discuss groundbreaking research on how subtle changes in brain chemistry could revolutionize treatments for neurodegenerative diseases and chronic pain. Lindsley highlights… Read More

Vanderbilt University is accelerating research innovation through a suite of internal funding programs designed to empower faculty across disciplines. These initiatives—developed by Chancellor Daniel Diermeier, Provost C. Cybele Raver, and Vice Provost for Research and Innovation Padma Raghavan—support projects ranging from AI-driven medical imaging to gene therapies… Read More

A new publication from the long-standing collaboration between WCNDD and Ono Pharmaceutical highlights a best-in-class in vivo tool compound targeting TREK ion channels. This study provides the first proof-of-concept for TREK activators as non-opioid analgesics and TREK inhibitors as pro-cognitive agents. Now featured among the most read in ACS… Read More

  The Warren Center for Neuroscience Drug Discovery at Vanderbilt University consists of a remarkable community dedicated to advancing the translation of basic science to novel therapeutics to treat serious brain disorders. In addition to our outstanding faculty, postdocs, and trainees who are at the forefront of our cutting-edge… Read More

​We’re thrilled to highlight the remarkable journey of Shanay Desai, a senior at Vanderbilt University, whose dedication to neuroscience and drug discovery is making strides in brain cancer research.Under the mentorship of Associate Professor Carrie Jones, Shanay designed an interdisciplinary major that combines his passions for neuroscience and biotechnology.Their collaboration… Read More